| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35105-1mg | |||
| Carrier-Free | NBP2-35105-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-52641-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-75912SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-52683-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-75900SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-81099-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-50435-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-81105-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-2701-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-52686-0.025mg | |||
![Western Blot: CD48/SLAMF2 Antibody (JE37-98) [NBP3-32157] - Western blot analysis of CD48/SLAMF2 on different lysates with Rabbit anti-CD48/SLAMF2 antibody (NBP3-32157) at 1/1,000 dilution. Lane 1: Raji cell lysate Lane 2: Jurkat cell lysate Lysates/proteins at 15 ug/Lane. Predicted band size: 27.7 kDa Observed band size: 40 kDa Exposure time: 80 seconds; 4-20% SDS-PAGE gel. Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (NBP3-32157) at 1/1,000 dilution was used in 5% NFDM/TBST at room temperature for 2 hours. Goat Anti-Rabbit IgG - HRP Secondary Antibody at 1:100,000 dilution was used for 1 hour at room temperature.](http://images.novusbio.com/fullsize/nbp3-32157_rabbit-cd48-slamf2-mab-je37-98-2782024163160.jpg "Western Blot: CD48/SLAMF2 Antibody (JE37-98) [NBP3-32157] - Western blot analysis of CD48/SLAMF2 on different lysates with Rabbit anti-CD48/SLAMF2 antibody (NBP3-32157) at 1/1,000 dilution. Lane 1: Raji cell lysate Lane 2: Jurkat cell lysate Lysates/proteins at 15 ug/Lane. Predicted band size: 27.7 kDa Observed band size: 40 kDa Exposure time: 80 seconds; 4-20% SDS-PAGE gel. Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (NBP3-32157) at 1/1,000 dilution was used in 5% NFDM/TBST at room temperature for 2 hours. Goat Anti-Rabbit IgG - HRP Secondary Antibody at 1:100,000 dilution was used for 1 hour at room temperature.")
![Immunohistochemistry: CD48/SLAMF2 Antibody (JE37-98) [NBP3-32157] - Immunohistochemical analysis of paraffin-embedded human colon tissue with Rabbit anti-CD48/SLAMF2 antibody (NBP3-32157) at 1/1,000 dilution. The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (NBP3-32157) at 1/1,000 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX.](http://images.novusbio.com/fullsize/nbp3-32157_rabbit-cd48-slamf2-mab-je37-98-29820241435245.jpg)
![Immunocytochemistry/Immunofluorescence: CRACC/SLAMF7 Antibody (1B9) [H00057823-M01] - Analysis of monoclonal antibody to SLAMF7 on HeLa cell . Antibody concentration 10 ug/ml.](http://images.novusbio.com/fullsize/CRACC-SLAMF7-Antibody-1B9-Immunocytochemistry-Immunofluorescence-H00057823-M01-img0002.jpg "Immunocytochemistry/Immunofluorescence: CRACC/SLAMF7 Antibody (1B9) [H00057823-M01] - Analysis of monoclonal antibody to SLAMF7 on HeLa cell . Antibody concentration 10 ug/ml.")
![Sandwich ELISA: CRACC/SLAMF7 Antibody (1B9) [H00057823-M01] - Detection limit for recombinant GST tagged SLAMF7 is 1 ng/ml as a capture antibody.](http://images.novusbio.com/fullsize/CRACC-SLAMF7-Antibody-1B9-Sandwich-ELISA-H00057823-M01-img0003.jpg)
![SDS-Page: Mouse IL-1ra/IL-1F3/IL1RN Protein [NBP2-35105]](http://images.novusbio.com/fullsize/Mouse-IL-1ra-IL-1F3-IL1RN-Protein-SDS-Page-NBP2-35105-img0001.jpg "SDS-Page: Mouse IL-1ra/IL-1F3/IL1RN Protein [NBP2-35105]")
![Immunohistochemistry: CD11a/CD18 Antibody (hu1124 (Efalizumab)) [NBP2-75912] - Anti-CD11a staining of formaldehyde fixed paraffin embedded rat spleen tissue, at 40x magnification. The human IgG1-chimeric version of hu1124 (NBP2-75912) was used to stain samples at a concentration of 3 ug/ml.](http://images.novusbio.com/fullsize/CD11a-CD18-Antibody-hu1124-Efalizumab-Immunohistochemistry-NBP2-75912-img0001.jpg "Immunohistochemistry: CD11a/CD18 Antibody (hu1124 (Efalizumab)) [NBP2-75912] - Anti-CD11a staining of formaldehyde fixed paraffin embedded rat spleen tissue, at 40x magnification. The human IgG1-chimeric version of hu1124 (NBP2-75912) was used to stain samples at a concentration of 3 ug/ml.")
![Flow Cytometry: CD30/TNFRSF8 Antibody (Ki-4) - Chimeric [NBP2-52683] - Flow-cytometry using anti-CD30 antibody Ki-4. Human lymphocytes were stained with an isotype control (panel A) or the rabbit-chimeric version of Ki-4 (NBP2-52683) before (B) or after anti-CD3/28 activation (C) at a concentration of 1 ug/ml for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody and cells analysed on a FACSCanto flow-cytometer.](http://images.novusbio.com/fullsize/CD30-TNFRSF8-Antibody-Ki-4-Chimeric-Flow-Cytometry-NBP2-52683-img0001.jpg "Flow Cytometry: CD30/TNFRSF8 Antibody (Ki-4) - Chimeric [NBP2-52683] - Flow-cytometry using anti-CD30 antibody Ki-4. Human lymphocytes were stained with an isotype control (panel A) or the rabbit-chimeric version of Ki-4 (NBP2-52683) before (B) or after anti-CD3/28 activation (C) at a concentration of 1 ug/ml for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody and cells analysed on a FACSCanto flow-cytometer.")
![Immunohistochemistry: CD4 Antibody (YNB46.1.8 (Campath-9H)) [NBP2-75900] - Anti-CD4 staining of formaldehyde fixed paraffin embedded rabbit spleen tissue, at 40x magnification. The rat IgG1-chimeric version of YNB46.1.8 (NBP2-75900) was used to stain samples at a concentration of 5 ug/ml.](http://images.novusbio.com/fullsize/CD4-Antibody-YNB46-1-8-Campath-9H-Immunohistochemistry-NBP2-75900-img0001.jpg "Immunohistochemistry: CD4 Antibody (YNB46.1.8 (Campath-9H)) [NBP2-75900] - Anti-CD4 staining of formaldehyde fixed paraffin embedded rabbit spleen tissue, at 40x magnification. The rat IgG1-chimeric version of YNB46.1.8 (NBP2-75900) was used to stain samples at a concentration of 5 ug/ml.")
![Western Blot: CD4 Antibody (YNB46.1.8 (Campath-9H)) - Azide and BSA Free [NBP2-75900] - Mouse thymus (lane 1) and mouse spleen (lane 2) were resolved on a 10% SDS PAGE gel and blots probed with NBP2-75900 at 1.5 ug/ml before being detected by a secondary antibody. The expected band size (51 kDa) is seen along with bands corresponding to dimers.](http://images.novusbio.com/fullsize/nbp2-75900_rat-monoclonal-cd4-antibody-ynb46-1-8-campath-9h-7420252211305.png)
![Western Blot: IFN-gamma Antibody (N3-P3A5A10) [NBP2-50435]](http://images.novusbio.com/fullsize/IFN-gamma-Antibody-N3-P3A5A10-Western-Blot-NBP2-50435-img0002.jpg "Western Blot: IFN-gamma Antibody (N3-P3A5A10) [NBP2-50435]")
![Immunohistochemistry: IFN-gamma Antibody (N3-P3A5/A10) [NBP2-50435] - Staining of a whole mount Zebra fish embryo.](http://images.novusbio.com/fullsize/IFN-gamma-Antibody-N3-P3A5A10-Immunofluorescence-NBP2-50435-img0001.jpg)
![Western Blot: Lymphotoxin-alpha/TNF-beta Antibody (3F12.2D3) - Chimeric [NBP2-81105] - Western Blot using Lymphotoxin-alpha/TNF-beta Antibody (3F12.2D3) [NBP2-81105]. Lipopolysaccharide(LPS)-treated human peripheral blood monocyte (PBM) lysate (35ug protein in RIPA buffer) was resolved on a 15% SDS PAGE gel and blots probed with the rabbit IgG-chimeric version of 3F12.2D3 [NBP2-81105] at 2 ug/ml before detection using an anti-rabbit secondary antibody. Protein was detected by chemiluminescence. The expected unmodified running size for Lymphotoxin alpha is 22.3kDa, though the form shown here is likely glycosylated. NBP2-81105 successfully detected Lymphotoxin alpha in LPS-treated human PBM samples.](http://images.novusbio.com/fullsize/Lymphotoxin-alpha-TNF-beta-Antibody-3F12-2D3-Chimeric-Western-Blot-NBP2-81105-img0002.jpg "Western Blot: Lymphotoxin-alpha/TNF-beta Antibody (3F12.2D3) - Chimeric [NBP2-81105] - Western Blot using Lymphotoxin-alpha/TNF-beta Antibody (3F12.2D3) [NBP2-81105]. Lipopolysaccharide(LPS)-treated human peripheral blood monocyte (PBM) lysate (35ug protein in RIPA buffer) was resolved on a 15% SDS PAGE gel and blots probed with the rabbit IgG-chimeric version of 3F12.2D3 [NBP2-81105] at 2 ug/ml before detection using an anti-rabbit secondary antibody. Protein was detected by chemiluminescence. The expected unmodified running size for Lymphotoxin alpha is 22.3kDa, though the form shown here is likely glycosylated. NBP2-81105 successfully detected Lymphotoxin alpha in LPS-treated human PBM samples.")
![Flow Cytometry: Lymphotoxin-alpha/TNF-beta Antibody (3F12.2D3) - Chimeric [NBP2-81105] - Flow-cytometry using the Lymphotoxin-alpha/TNF-beta Antibody (3F12.2D3) [NBP2-81105]. U937 cells were fixed using 2% PFA, permeabilised using 0.5% Triton and stained with unimmunized rabbit IgG antibody (isotype control, black line) or the rabbit IgG-chimeric version of 3F12.2D3 (NBP2-81105, blue line) at a dilution of 1:100 for 1h at RT. After washing, bound antibody was detected using a goat anti-rabbit IgG AlexaFluor 488 antibody at a dilution of 1:1000 and cells analyzed using a FACSCanto flow-cytometer.](http://images.novusbio.com/fullsize/Lymphotoxin-alpha-TNF-beta-Antibody-3F12-2D3-Chimeric-Flow-Cytometry-NBP2-81105-img0001.jpg)
![Flow Cytometry: CD11a/CD18 Antibody (hu1124 (Efalizumab)) - Chimeric [NBP2-52686] - Flow-cytometry using the anti-CD11a research biosimilar antibody Efalizumab. Human lymphocytes were stained with an isotype control (NBP2-52638, panel A) or the rabbit-chimeric version of Efalizumab (NBP2-52686, panel B) at a concentration of 1 ug/ml for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody and cells analysed on a FACSCanto flow-cytometer.](http://images.novusbio.com/fullsize/CD11a-CD18-Antibody-hu1124-Efalizumab-Chimeric-Flow-Cytometry-NBP2-52686-img0001.jpg "Flow Cytometry: CD11a/CD18 Antibody (hu1124 (Efalizumab)) - Chimeric [NBP2-52686] - Flow-cytometry using the anti-CD11a research biosimilar antibody Efalizumab. Human lymphocytes were stained with an isotype control (NBP2-52638, panel A) or the rabbit-chimeric version of Efalizumab (NBP2-52686, panel B) at a concentration of 1 ug/ml for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody and cells analysed on a FACSCanto flow-cytometer.")